$Regulus Therapeutics (RGLS.US)$$Bio-Techne (TECH.US)$Bio-Techne And Regulus Therapeutics Announced Continued Technical And Clinical Collaboration Following Regulus' Topline Results From The Second Cohort Of Phase 1B Multiple Ascending Study Of RGLS8429 For Autosomal Dominant Polycystic Kidney Disease
Bio-Techne股票讨论
2022前三季度营收增长22%,营业利润增长28%,净利润受其它收入项影响增长了68%。
目前48倍市盈率,45倍市盈率TTM和营业利润增速相比没有太多折扣,吸引力不大。
涨幅
1. $英国保诚 (PUK.US)$ - 猜涨跌 3.18%
2. $Science Applications International (SAIC.US)$ 涨幅1.29%
3. $以色列化学 (ICL.US)$ 涨幅1.01%
4. $诺华制药 (NVS.US)$ 涨幅0.56%
5. $美高梅 (MGM.US)$ 涨0.4%
下跌
1. $威富集团 (VFC.US)$ 下跌3.34%
2. $Advanced Drainage (WMS.US)$ - 跌 0....
暂无评论